Joffe B, Li G, Gorroochurn P, DeCastro G, Lenis A, McKiernan J
J Robot Surg. 2025; 19(1):78.
PMID: 39987334
DOI: 10.1007/s11701-025-02242-3.
Sah A, Gupta A, Garg S, Yadav N, Ahmad Khan M, Das C
Abdom Radiol (NY). 2024; .
PMID: 39688674
DOI: 10.1007/s00261-024-04746-2.
Tian X, Liu J, Yi C, You X, Yuan C
Discov Oncol. 2024; 15(1):700.
PMID: 39580569
PMC: 11585529.
DOI: 10.1007/s12672-024-01580-2.
Yang Y, Zhang Z, Zhang H, Liu M, Zhang J
Front Oncol. 2024; 14:1467775.
PMID: 39575426
PMC: 11578869.
DOI: 10.3389/fonc.2024.1467775.
Yerukala Sathipati S, Jeong S, Sharma P, Mayer J, Sharma R, Ho S
Mol Ther Oncol. 2024; 32(4):200874.
PMID: 39399813
PMC: 11467672.
DOI: 10.1016/j.omton.2024.200874.
Novel Utilization of Protrieve™ to Decrease Embolization Risk During Radical Nephrectomy With Inferior Vena Cava (IVC) Thrombectomy: A Case Report.
Cooper S, Yankelevich G, Clarke H, Lin A
Cureus. 2024; 16(8):e68185.
PMID: 39347317
PMC: 11439480.
DOI: 10.7759/cureus.68185.
Comprehensive analysis of ETS1 expression and its prognostic value in clear cell renal cell carcinoma.
Mo M, Zhu Q, Yang L, Deng Y, Yu Y, Zhou Z
Am J Transl Res. 2024; 16(4):1062-1080.
PMID: 38715839
PMC: 11070354.
DOI: 10.62347/QNSV5278.
PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study.
Reimold P, Tosev G, Kaczorowski A, Friedhoff J, Schwab C, Schutz V
Diagnostics (Basel). 2024; 14(7).
PMID: 38611655
PMC: 11011373.
DOI: 10.3390/diagnostics14070741.
Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study.
Lu Z, Yin Y, Rao T, Xu X, Zhao K, Liu Z
BMC Cancer. 2024; 24(1):439.
PMID: 38594655
PMC: 11005164.
DOI: 10.1186/s12885-024-12196-8.
VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line.
Pilz J, Klein M, Neumann-Haefelin E, Ganner A
J Kidney Cancer VHL. 2024; 11(1):12-18.
PMID: 38304003
PMC: 10834178.
DOI: 10.15586/jkcvhl.v11i1.322.
Renal cell carcinoma (RCC) spreading to the larynx: an unusual condition.
Teran A, Martinez Zamorano M, Trujillo Ortiz J, Cerna Arriaga J
BMJ Case Rep. 2024; 17(1).
PMID: 38272511
PMC: 10826486.
DOI: 10.1136/bcr-2023-255459.
LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration.
Lu L, Lei Y, Li Y, Wang L
Aging (Albany NY). 2024; 16(2):1484-1495.
PMID: 38226972
PMC: 10866424.
DOI: 10.18632/aging.205440.
Clear cell renal cell carcinoma with mutation: a report of two cases.
Lee J, Thuzar M, DiPoto-Brahmbhatt A, Chaudoir C, Tanner A, Fazili T
Am J Clin Exp Urol. 2023; 11(5):429-434.
PMID: 37941648
PMC: 10628621.
Perioperative, Functional, and Oncologic Outcomes of On-Clamp Versus Off-Clamp Partial Nephrectomy: An Updated Meta-analysis of 9027 Patients.
Serag H, Agag A, Naushad N, Mukherjee A, Harrington-Vogt M, Ali Deb A
Urol Res Pract. 2023; 49(2):79-95.
PMID: 37877854
PMC: 10192728.
DOI: 10.5152/tud.2023.22207.
The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma.
Zhang B, Han D, Yang L, He Y, Yang S, Wang H
BMC Cancer. 2023; 23(1):986.
PMID: 37845657
PMC: 10577979.
DOI: 10.1186/s12885-023-11419-8.
A Neurosurgical Perspective on Brain Metastases from Renal Cell Carcinoma: Multi-Institutional, Retrospective Analysis.
Semenescu L, Tataranu L, Dricu A, Ciubotaru G, Radoi M, Rodriguez S
Biomedicines. 2023; 11(9).
PMID: 37760926
PMC: 10526360.
DOI: 10.3390/biomedicines11092485.
Regulator of G protein signaling-1 regulates immune infiltration and macrophage polarization in clear cell renal cell carcinoma.
Liu K, Xia D, Bian H, Peng L, Dai S, Liu C
Int Urol Nephrol. 2023; 56(2):451-466.
PMID: 37735297
PMC: 10808153.
DOI: 10.1007/s11255-023-03794-9.
Identification of microRNA editing sites in clear cell renal cell carcinoma.
Liu Y, Guo S, Xie W, Yang H, Li W, Zhou N
Sci Rep. 2023; 13(1):15117.
PMID: 37704698
PMC: 10499803.
DOI: 10.1038/s41598-023-42302-y.
ANXA13 promotes cell proliferation and invasion and attenuates apoptosis in renal cell carcinoma.
Niu X, Zhao K, Zheng Y, Wang Y, Liu R, Zhang Y
Heliyon. 2023; 9(8):e18009.
PMID: 37520951
PMC: 10374933.
DOI: 10.1016/j.heliyon.2023.e18009.
Clinical Outcomes of Total En Bloc Spondylectomy for Previously Irradiated Spinal Metastases: A Retrospective Propensity Score-Matched Comparative Study.
Yokogawa N, Kato S, Shimizu T, Kurokawa Y, Kobayashi M, Yamada Y
J Clin Med. 2023; 12(14).
PMID: 37510719
PMC: 10380676.
DOI: 10.3390/jcm12144603.